|
John A. Williams
CEO and Chairman, Board of Directors
John Williams joined United Federal of Rocky Mount, NC, in 1971 and later served
as its President, Director and Chief Executive Officer through 1986. He
co-founded Unity Bank in 1988 and First Carolina State Bank in 1999, having
served as its Chairman of the Board. In addition to his activities in commercial
and residential land development, focusing on coastal timeshare, campground, car
dealership, funeral home, cemetery, and farm development, Mr. Williams was
elected Edgecombe County Commissioner.
Mr. Williams was educated in the Edgecombe County Public Schools and graduated from the Electronic Computer Programming Institute of Raleigh in 1971. He completed the Executive Development Academy at the University of Georgia in Athens in 1975 and the Management of Managers School at the University of Michigan in Ann Arbor in 1977.
Mr. Williams has been affiliated with BioSignia for several years, joining the
Company as a member of its board in 2002.
Timothy J. Smith, Ph.D.
COO and President, Board of Directors
|
Dr.
Smith holds a Ph.D. in Biomedical Sciences from the Quillen College of Medicine at East Tennessee State
University and an M.S. in Microbiology from its
School of Public Health. Over a period of some 30
years, he has held a variety of management and
research positions within the healthcare sector,
primarily in the areas of diagnostic testing and
development. For a period of time he owned and
operated three clinical laboratories, all of which
were acquired by major companies. Prior to joining BioSignia, Dr. Smith held a variety of senior
management positions with Roche Biomedical
Laboratories (now LabCorp), Burlington, NC, and F.
Hoffman LaRoche (Roche), Ltd., Nutley, NJ and also
its world headquarters in Basel, Switzerland. In his
last position, Dr. Smith had responsibility for the
company's specialty business units - taking emerging
technologies from concept to market delivery. Dr.
Smith's interest in BioSignia's technical concept
came as a natural extension of his diagnostics
experience. The founders of BioSignia recruited him
in 1997 to lead the Company's transition from
concept to market. |
|
|
|
|
Guizhou Hu, M.D., Ph.D.
Senior Vice President, Science and Technology
|
|
Dr.
Hu was awarded an M.D. from Beijing Medical
University, and an M.S. in nutritional toxicology
and a Ph.D. in epidemiology from Cornell University.
Dr. Hu joined BioSignia in 1998 following his
post-doctoral work at Cornell. A Deputy Minister
from the Chinese Academy of Preventive Medicine, Dr.
Junshi Chen, commented that Dr. Hu “may be one of
the brightest young minds to have ever come to
America from China for further study.” His
professors and mentors from Cornell University have
confirmed this with similar comments. Dr. Hu’s
efforts have produced numerous proprietary products
for the Company and ingenious solutions for the
marketplace. He is also named on the patent for
BioSignia’s Synthesis Analysis technology. The
technological discoveries he has made while at
BioSignia have been praised by some of the world’s
most prominent epidemiologists and statisticians. In
April, 2006, Dr. Hu won the Triangle Business
Journal’s Health Care Heroes Award in the innovator
category. He is an excellent presenter and is quite
at ease in environments ranging from the very
scientific or academic to sales and boardroom
settings. |
Ron Evans
Senior Vice President of Sales
|
|
Mr.
Evans has over twenty four years of distinguished
executive sales management and service leadership in
the healthcare field. For over twenty two years,
working for a national clinical lab, Mr. Evans held
positions with increasing responsibilities. His
teams were responsible for unprecedented growth of
revenue and profit margins in the lab industry,
achieving the highest awards within the company
multiple times. His most recent position, Mr. Evans
was Vice President of sales with responsibilities
for over 120m in revenue. Mr. Evans has a bachelor’s
degree in Business Administration from Elon
University and played professional baseball for five
years with the Boston Red Sox organization. |
|
|
| |
|
| |
|